Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis

Vinod H. Thourani(Valve (United States)), Martin B. Leon(Columbia University Irving Medical Center), Vasilis Babaliaros(Valve (United States)), E. Murat Tuzcu(Cleveland Clinic), Michael J. Mack(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Susheel Kodali(Columbia University Irving Medical Center), Ralph B. D’Agostino(Wake Forest University), D. Craig Miller(Harvard University), Rupa Parvataneni(UCSF Helen Diller Family Comprehensive Cancer Center), Maria Alu(Columbia University Irving Medical Center), Lars G. Svensson(Cleveland Clinic), John G. Webb(St. Paul's Hospital), Raj Makkar(Cedars-Sinai Medical Center), Rebecca T. Hahn(Columbia University Irving Medical Center), Scott Lim(Vancouver Coastal Health Research Institute), Neil J. Weissman(MedStar Washington Hospital Center), Jeffrey W. Moses(Good Samaritan University Hospital), Howard C. Herrmann(University of Pennsylvania), Mathew Williams(Mount Sinai Health System), Wael A. Jaber(Cleveland Clinic), Dean J. Kereiakes(Health Net), S. Chris Malaisrie, Brian Whisenant(Intermountain Healthcare), Samir Kapadia(Cleveland Clinic), Kevin L. Greason(Mayo Clinic), Chandan Devireddy, Richard W. Smalling(Memorial Hermann), David J. Cohen(Baim Institute for Clinical Research), Gorav Ailawadi(University of Michigan), Craig R. Smith(University of Arizona), Wilson Y. Szeto(Mount Sinai Hospital), Jonathon Leipsic(University of British Columbia), Rakesh M. Suri, Philippe Pîbarot(Emory University)

The Lancet

April 3, 2016

Cited by 1,030

Related Papers

|Circulation|1998|9.6k

|Circulation|2008|7.4k

|New England Journal of Medicine|2010|7.2k

|New England Journal of Medicine|2011|6.4k

|Circulation|2007|5.4k